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AbstrACt
Objective To investigate whether the nature of the 
decision about receiving neuraxial labour analgesia is 
associated with breastfeeding initiation success (BIS), 
defined as exclusive breastfeeding until discharge 
associated with postnatal weight loss <7% at 60 hours 
from birth.
Design Single-centre community-based cohort study.
setting An Italian baby-friendly hospital, from 1 July 2011 
to 22 September 2015.
Participants Inclusion criteria: women vaginally delivering 
singleton cephalic newborns and willing to breastfeed. 
Exclusion criteria: women who delivered in uterus-dead 
fetuses, were single or requested but did not receive 
neuraxial analgesia. Overall, 775 out of the 3628 enrolled 
women received neuraxial analgesia.
results Compared with women who tried to cope with 
labour pain, those who decided a priori to receive neuraxial 
analgesia had less BIS (planned vaginal birth: 2121/3421 
(62.0%), vs 102/207 (49.3%; p<0.001; risk difference 
(RD), 12.7%); actual vaginal birth: 1924/2994 (64.3%), 
vs 93/189 (49.2%; p<0.001; RD, 15.1%)). Multivariable 
analyses with antelabour-only confounders confirmed 
both associations (planned vaginal birth: relative risk (RR), 
0.65; 95% CI, 0.48 to 0.87; actual vaginal birth: RR, 0.59; 
95% CI, 0.43 to 0.80). Although women who requested 
analgesia as a last resort had less BIS than did those 
successfully coping with labour pain in the bivariable 
analyses (planned vaginal birth: 1804/2853 (63.2%), vs 
317/568 (55.8%; p=0.001; RD, 7.4%); actual vaginal 
birth: 1665/2546 (65.4%), vs 259/448 (57.8%; p=0.002; 
RD, 7.6%)), multivariable analyses with either antelabour-
only or peripartum confounders did not confirm these 
associations (planned vaginal birth: RR, 0.99; 95% CI, 0.80 
to 1.23; actual vaginal birth: RR, 0.90; 95% CI, 0.69 to 
1.16).
Conclusions Compared with trying to cope with labour 
pain, a priori choice of neuraxial analgesia is negatively 
associated with BIS. Conversely, compared with having 
successfully coped with pain, requesting neuraxial 
analgesia as a last resort is not negatively associated with 
BIS.
IntrODuCtIOn 
A growing body of evidence now supports 
the consideration of breastfeeding as the 
normative standard for infant feeding.1–11 
In the past, the risk factors for breastfeeding 
failure have been investigated extensively 
to steer policies and interventions aimed at 
promoting breastfeeding success. Among 
the several medical interventions that could 
affect breastfeeding success, the role of 
neuraxial labour analgesia has been investi-
gated thoroughly. Several studies have found 
that neuraxial labour analgesia can negatively 
impact either the initiation or duration of 
exclusive breastfeeding.12–18 Although some 
reviewers have also quoted reassuring studies, 
to date, consistent results have not been 
reported.19 20 The recent release of the ‘Intra-
partum Care for a Positive Childbirth Experi-
ence’ guidelines by the WHO21 pushes for an 
in-depth analysis of the relationship between 
neuraxial labour analgesia and breastfeeding. 
Indeed, these guidelines recommend 
pharmacological labour analgesia (either 
strengths and limitations of this study
 ► The study enrolled a large and almost unselected 
population of mother–baby dyads due to the limited 
exclusion criteria.
 ► The comparison of groups is meaningful because 
physiologic birth was the true reference point.
 ► The outcome measure is robust because it includ-
ed an index of the newborn's nutritional status at 
discharge.
 ► The generalisability of the findings may be limited 
due to the observational, single-centre design.
 ► The baby-friendly designation of the hospital may 
introduce a possible selection bias.
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neuraxial analgesia or parenteral opioid administra-
tion) ‘for healthy pregnant women requesting pain relief 
during labour, depending on a woman's preferences’. 
Moreover, these guidelines underline that women who 
expressed an ‘a priori desire for analgesia’ to experience 
a pain-free labour may be different from those who only 
‘requested analgesia as a last resort’ when the pain level 
was overwhelming.
To the best of our knowledge, the association between 
the nature of the decision about receiving neuraxial 
labour analgesia and breastfeeding success has not yet 
been investigated. Thus, we aimed to investigate whether 
the decision about receiving neuraxial labour analgesia, 
either a priori or as a last resort, was associated with 
breastfeeding initiation success (BIS) at discharge from 
a baby-friendly hospital. Specifically, we aimed to test two 
hypotheses. First, among women trying to deliver vagi-
nally, we hypothesised that women who choose analgesia 
a priori have a lower BIS than do those who try to cope 
with labour pain. Second, among women who try to cope 
with labour pain, we hypothesised that those who request 
analgesia only as a last resort have similar BIS as those 
who successfully cope with labour pain.
MethODs
This manuscript adheres to the Strengthening the 
Reporting of Observational Studies in Epidemiology 
guidelines. The Aosta Valley community comprises 125 
000 inhabitants, and the Parini Regional Hospital is the 
only available facility in the county. There are 1200 deliv-
eries each year at this hospital, and since 2010, it has 
been repeatedly designated by Unicef as a baby-friendly 
hospital. All women who delivered at the facility between 
1 July 2011 and 22 September 2015 were screened for 
eligibility. All women who planned to give birth vagi-
nally to a singleton cephalic newborn and expressed the 
desire to breastfeed the baby were included in the study. 
Women who delivered an in uterus-dead fetus, who were 
currently single or who requested neuraxial analgesia 
but did not receive it due to technical difficulties were 
excluded. Single mothers were excluded because only a 
few of the potential participants were single and the anal-
yses included several confounders that were relevant to 
both parents as a couple.
The study predictors were the a priori choice for anal-
gesia and the request for analgesia as a last resort. Women 
were considered as choosing neuraxial labour analgesia 
a priori if they chose to receive the analgesia by them-
selves, and requested it on arrival at the delivery room 
without considering alternative means of pain relief 
offered by the facility's midwives. On the other hand, 
women were considered as requesting analgesia as a last 
resort if they requested it later during labour progression, 
or only after considering other techniques offered by 
the facility's midwives (postures, massage, water immer-
sion, etc). In the latter case, the trigger for the request 
was an overwhelming level of pain or an unmanageable 
sense of control over the labour or both, and the woman's 
decision was shared and supported by healthcare profes-
sionals. The decision about receiving neuraxial analgesia 
was first collected by the attending midwife when the 
women arrived at the delivery room (ie, when the active 
phase of labour was beginning or when labour would be 
induced with oxytocin). The need of labour induction 
was not considered a routine indication for neuraxial 
analgesia implementation or proactive epidural catheter 
placement. Accordingly, the woman's decision about 
receiving analgesia was collected by the duty gynaecolo-
gist when the woman signed the informed consent for the 
induction of labour and it was reported by the attending 
midwife in the delivery room. The women were then 
divided into two groups, those trying to cope with labour 
pain on their own (trying to cope group), and those 
who chose to receive analgesia a priori (a priori choice 
group). Thereafter, should women in the trying to cope 
group give up and demand analgesia, they were classified 
as requesting analgesia as a last resort (last resort group). 
In contrast, women who did not require neuraxial labour 
analgesia were categorised as having successfully coped 
with the pain (successful coping group).
Neuraxial labour analgesia was administered by the 
duty anaesthetist using the same technique in the a priori 
choice and last resort groups. The analgesia was either 
a combined spinal-epidural or a classic epidural, and in 
either case, a low-dose, high-volume mixture of ropiva-
caine and sufentanil was administered as intermittent 
on-demand boluses by the duty anaesthetist to pursue a 
verbal rating pain score from 4 to 6 out of 10 according to 
the woman's wishes.
The study endpoint was BIS, as collected by the 
attending paediatrician at hospital discharge. BIS was 
defined as exclusive breastfeeding during the entire 
hospital stay,22 23 associated with a postnatal weight loss 
less than 7% at 60 hours from birth.24 25 Mother–baby 
dyads' socio-demographic, anamnestic, peripartum and 
breastfeeding data were collected by study investigators, 
as retrieved from their computerised medical charts.
sample size
Personal data (Wetzl RG, A baby-friendly hospital, 2011) 
showed a ratio of 0.07 between women in the a priori 
choice group and those in the trying to cope group. 
Therefore, it was hypothesised that 208 women in the 
a priori choice group and 2975 women in the trying to 
cope group would be necessary to detect a 10% differ-
ence in BIS at discharge (from 0.55 to 0.45).26 At the end 
of the recruitment period, the power requirement for the 
planned endpoint of the study was wholly satisfied by the 
actual size of the enrolled population.
statistical analysis
The descriptive data were presented as the number (n) 
and percentage for categorical variables, and as the 
mean, SD, median and the 10th and 90th percentiles 
for continuous variables. Bivariable associations between 
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predictors, confounders and the endpoint were evaluated 
through the χ2 test using a two-tailed alpha of 0.05 and a 
power of 0.80 (1 – beta). Yates's correction for continuity 
was used when the expected value for at least one cell was 
less than 5 in a 2×2 contingency table.
The confounders that, according to the current litera-
ture, could be associated with BIS were entered into the 
analysis and grouped as antelabour-only and peripartum 
confounders. In addition to antelabour confounders, the 
peripartum confounders included the intrapartum and 
postpartum ones. To be considered an antelabour-only 
confounder, a factor was required to meet all the 
following criteria: (1) it must be present before labour 
initiation, that is, before exposure to analgesia; (2) there 
must be a theoretical basis for an association between the 
confounder and the endpoint; and (3) it should be impos-
sible to reverse the temporal sequence.27 Online supple-
mentary table A1 and 2 indicate the antelabour-only and 
peripartum confounders, and their diagnostic and cate-
gorising criteria.
In the analyses, if a categorical variable had three or 
more possible values, dummy variables were created. In 
most cases, previously published and validated cut-offs 
were used. If the percentile cut-off was used, the 10th 
and 90th percentiles were calculated for the entire popu-
lation of women who delivered in the facility (Wetzl RG, 
Aosta whole birth cohort, 2016). To adjust for the risk 
estimates in the main effects, considering the dichoto-
mous endpoint, a log-linear multivariable regression 
analysis was used and the confounders were entered 
using a forward selection procedure. p<0.10 was consid-
ered acceptable to enter the variable into the log-linear 
regression model. Prior to multivariable analyses, multi-
collinearity was assessed at each step of the analyses. 
Values of condition index <15, tolerance >0.10 and vari-
ance inflation factor <10.0 were considered acceptable. 
The accuracy of the log-linear regression model was 
assessed using Nagelkerke's R2 coefficient of determina-
tion. The results were reported as regression coefficient, 
relative risk (RR), 95% CI, p value and risk difference 
(RD), as a measure of the absolute risk. Records with 
missing data were excluded from the multivariable 
log-linear analyses.
Data were analysed first on the whole population 
of recruited women (first-step) and then excluding 
women who underwent an unplanned caesarean section 
(second-step). At each step, data analyses were conducted 
following a two-stages design. For the first study hypoth-
esis, BIS was compared between women in the trying to 
cope group and the a priori choice group. For the second 
study hypothesis, within the trying to cope group, BIS was 
evaluated by comparing women in the successful coping 
group with those in the last resort group. At each stage, 
multivariable analyses were performed in sequence, first 
with the antelabour-only confounders and then with the 
antelabour and peripartum confounders together.
Data were collected and tabulated using the File-
Maker 11 Pro Relational Database (FileMaker, FileMaker 
International, Santa Clara, California, USA). Statistical 
analyses were performed using SPSS V.22 (IBM SPSS 
Statistics).
Patient and public involvement
No parents were directly involved in setting the questions, 
selecting the outcome measure, designing and imple-
menting the study. No parents were involved in the inter-
pretation or writing up of study results.
results
The flow chart of the study steps has been presented 
in figure 1. From the set of eligible women (n=3685), 
the following were excluded: 11 women with intra-
uterine fetal death, 40 single mothers and 6 women who 
requested but did not receive analgesia due to technical 
difficulties. Finally, for the first-step anlyses 3628 women 
were recruited (attempted vaginal birth population). For 
the second-step analyses, 445 women who underwent an 
unplanned caesarean section were excluded. Therefore, 
the population of actual vaginal birth comprised 3183 
women.
No differences in basal characteristics were found 
between the women who were excluded from the study 
and those who were included (data not shown). Missing 
data values regarding the 50 considered confounders 
represented 0.003% of all the collected data, and dele-
tion of the involved records did not impact the power 
requirements for the study endpoint.
Descriptive analysis
Tables 1-2 show the characteristics of the study's groups 
in the planned vaginal birth (n=3628) and actual vaginal 
birth population (n=3183), respectively. Online supple-
mentary tables A3–11 show the basal characteristics of the 
parents and newborns, the dyads' outcomes in caesarean 
and vaginal deliveries, and the basal and technical char-
acteristics of administered neuraxial labour analgesia. 
The two groups of women who received neuraxial anal-
gesia (whole cohort, n=775; a priori choice group, n=207; 
and last resort group, n=568) showed no differences 
regarding the following variables: cervical dilation at 
the time of analgesia request, percentage of combined 
spinal-epidurals versus classic epidurals administered, 
number of administered boluses, cumulative opioid or 
local analgesic administered doses, and mother's satis-
faction registered at least 24 hours after the birth (online 
supplementary table A7).
Outcome data
A significant reduction in BIS at discharge was found 
in both women who chose analgesia a priori (planned 
vaginal birth: trying to cope group vs a priori choice 
group, 2121/3421 (62.0%; 95% CI, 60.4% to 63.6%), 
vs 102/207 (49.3%; 95% CI, 42.5% to 56.1%; p<0.001; 
RD=12.7%); actual vaginal birth: trying to cope group vs 
a priori choice group, 1924/2994 (64.3%; 95% CI, 62.5% 
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to 66.0%), vs 93/189 (49.2%; 95% CI, 42.1% to 56.3%; 
p<0.001; RD=15.1%)), and women who requested anal-
gesia as a last resort (planned vaginal birth: successful 
coping vs last resort group, 1804/2853 (63.2%; 95% CI, 
61.5% to 65.0%), vs 317/568 (55.8%; 95% CI, 51.7% 
to 59.9%; p=0.001; RD=7.4%); actual vaginal birth: 
successful coping vs last resort group, 1665/2546 (65.4%; 
95% CI, 63.5% to 67.2%), vs 259/448 (57.8%; 95% CI, 
53.2% to 62.4%; p=0.002; RD=7.6%)).
In the group of women trying to deliver vaginally, 
multivariable log-linear analyses with antelabour-only 
confounders showed that women who chose analgesia a 
priori had significantly less BIS than those who tried to 
cope with labour pain (planned vaginal birth: RR=0.65; 
95% CI, 0.48 to 0.87; p=0.004; actual vaginal birth: 
RR=0.59; 95% CI, 0.43 to 0.80; p=0.001) (table 3).
In contrast, in the group of women trying to cope 
with labour pain, compared with those who succeeded 
in coping with labour pain, the group of women who 
requested analgesia as a last resort did not show an inde-
pendent association with BIS according to multivariable 
log-linear analyses with either antelabour-only or antela-
bour and peripartum confounders considered together 
(planned vaginal birth: RR=0.99; 95% CI, 0.80 to 1.23; 
p=0.955; actual vaginal birth: RR=0.90; 95% CI, 0.69 to 
1.16; p=0.405) (table 4). On the contrary, being nullipa-
rous or older, presenting with a higher body mass index 
or a greater pregnancy weight gain, or having delivered 
a newborn at a younger gestational age were associated 
with a decreased BIS at discharge.
DIsCussIOn
The findings of the present study conducted in a baby-
friendly hospital setting demonstrate that a woman's a 
priori choice of receiving neuraxial labour analgesia was 
independently associated with reduced BIS at discharge 
compared with women trying to cope with labour pain. In 
contrast, a woman's request for neuraxial labour analgesia 
as a last resort led to similar BIS as that among women 
who succeeded in coping with labour pain.
The first results of the present study could be partially 
explained hypothesising a greater motivational vulner-
ability towards breastfeeding among women choosing a 
priori to receive neuraxial labour analgesia as compared 
with women trying to cope with labour pain on their own, 
comprising also the group of women requesting neuraxial 
analgesia as a last resort. If this is true, women who choose 
Figure 1 Flow chart of the study steps. For the first study hypothesis, among the women planning to give birth vaginally, 
breastfeeding initiation success (BIS) was compared between women who chose analgesia a priori and those trying to cope 
with labour pain. For the second study hypothesis, among the women who tried to cope with labour pain, BIS was compared 
between women who requested analgesia only as a last resort and those who coped with labour pain successfully.
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a priori to receive neuraxial labour analgesia would prob-
ably need increased peripartum breastfeeding support if 
they expressed the desire to breastfeed the baby. Although 
it cannot be ruled out that a mother's open externalisa-
tion of having chosen neuraxial labour analgesia a priori 
could simply represent a personal communicative style, 
we did not find studies addressing this topic. The second 
result of the present study could probably be explained 
hypothesising that, among the women trying to cope with 
labour pain, those requesting neuraxial analgesia as a last 
resort intrapartum received a medical intervention which 
at least seemed to not interfere with labour progres-
sion, probably because it was necessitated by actual or 
perceived difficulties of their own birth process. However, 
to the best of our knowledge, no previous study in litera-
ture has addressed this topic.
The findings of this study on the association of the well-
known peripartum confounders with the breastfeeding 
initiation process were consistent with those already 
emerging from the current literature, except those 
related to older maternal age.28–42 Regarding the associa-
tion between older maternal age and breastfeeding, data 
in the current literature are conflicting.17 43 Indeed, in the 
present study, the association between advanced maternal 
age and reduced breastfeeding success was confirmed by 
multivariable analyses because the sample included an 
almost unselected population of both nulliparous and 
multiparous women.
The effect of choosing to receive neuraxial labour anal-
gesia on breastfeeding success remains a controversial 
issue. Previous studies reported breastfeeding initiation 
difficulties at hospital discharge in women who chose to 
receive neuraxial labour analgesia,12–16 with some studies 
even inferring a dose–response relationship between the 
dose of a particular opioid (usually fentanyl) and the 
proportion of mothers who showed breastfeeding initia-
tion difficulties.17 18 However, other studies did not report 
any association between the choice to receive neuraxial 
labour analgesia and breastfeeding initiation difficul-
ties.43–55 The inconsistency of these findings is partially 
due to widespread deficiencies in study design.56 To the 
best of our knowledge, no study has considered breast-
feeding success in women who chose to receive neuraxial 
analgesia, taking into account the nature of the request.
In addition to providing interesting clinical remarks, 
the present study has several limitations. First, we did 
not assess the coping styles of all the labouring women, 
including those who did not request analgesia at all, using 
the type of coping scale recently proposed by the Amer-
ican College of Obstetricians and Gynecologists.57 Second, 
the baby-friendly designation of the hospital where the 
study was conducted could have impacted the women's 
choice of the delivery setting, leading to a selection bias 
in the enrolled population. Some women could have 
chosen not to deliver in a baby-friendly hospital because 
they were afraid of feeling pressured into breastfeeding 
their newborn. On the other hand, some foreign women 
could have chosen to deliver their child in a baby-friendly 
hospital, which also offers free access to neuraxial labour 
analgesia at all times. To control for the latter selection 
bias, we included residence as a confounder in the multi-
variable analyses. Regarding the first bias, the percentage 
of women who resided in the valley and did not deliver at 
the study hospital was less than 3.9% of the whole obstetric 
population, including women who underwent a planned 
caesarean section (data retrieved from the regional 
health data register). Third, even though a randomised 
controlled trial is preferable when assessing the impact 
of a new treatment, the present study employed an obser-
vational design. Actually, should potential side-effects or 
adverse reactions of the administered drugs be investi-
gated, a well-conducted observational study will not be 
irrelevant due to the particularly delicate ethical issues 
arising in obstetric or neonatology research.58 Fourth, 
the limitation stemming from the asynchrony in the time 
of collecting the choice of analgesia between the woman 
presenting in the active phase of labour and women 
undergoing labour induction needs to be acknowledged. 
Lastly, although a large number of peripartum variables 
were included in the multivariable analyses, the risk of 
residual confounding factors cannot be excluded.
In the statistical analyses we have not taken into account 
the technique used for administering neuraxial analgesia 
(spinal-epidural or classical epidural), since both tech-
niques are major neuraxial blocks and are considered 
substantially equivalent, either in terms of analgesic effi-
cacy, or of side effects,59 as underlined by the Cochrane 
Collaboration in a recent meta-analysis on the effects 
of neuraxial analgesia on the delivery's and newborn's 
outcomes.60
The generalisability of the present findings could be 
limited by its single-centre design. First, because the 
study was conducted in a baby-friendly hospital setting, 
we could have selected women with high motivation to 
breastfeed. Indeed, the any-breastfeeding proportion at 
discharge was 98.2%, and the exclusive breastfeeding 
proportion was 82.9%. Moreover, in the present study, the 
cumulative doses of the administered drugs were very low 
compared with those reported in the literature.61 62 These 
low cumulative drug doses were due not only to technical 
choices adopted regarding the administered neuraxial 
analgesia but also to the intermittent on-demand pattern 
of drug administration by the duty anaesthetist and to 
the moderate level of pain control pursued according 
to women's wishes. However, these technical choices 
were consistent with the emerging tendency of offering 
a less aggressive neuraxial analgesia, as reported by the 
Cochrane Collaboration.60 Finally, regarding the drugs 
which were chosen for neuraxial analgesia, ropivacaine 
and sufentanil were administered as the local anaesthetic 
and opioid, respectively, while bupivacaine and fentanyl 
are used most frequently during delivery worldwide. 
Notwithstanding, the choice of sufentanil seems to be 
more appropriate in terms of fetal exposure.63
The present study also has a few strengths. First, the very 
limited number of exclusion criteria allowed us to recruit 
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a population of mother–baby dyads that was not only large 
but also almost unselected. Only 57 women (1.5%) were 
excluded from the whole cohort of 3685 women planning 
to give birth vaginally and willing to breastfed. Therefore, 
the present results seemed to be deeply contextualised 
in the actual complexity of a real birth setting in a baby-
friendly hospital. Second, the two-stages design of the 
data analyses allowed us to use a large number of physio-
logical deliveries as the true comparator. Indeed, 40.7% 
of the enrolled women delivered without any medical 
intervention. Lastly, in contrast to previous studies, the 
BIS definition included newborn weight loss at 60 hours 
from birth as an index of the newborn's nutritional status 
at discharge.
COnClusIOns
Based on the findings of the present study conducted 
in a baby-friendly hospital setting, the a priori choice of 
neuraxial labour analgesia is negatively associated with 
BIS as compared with women trying to cope with labour 
pain on their own. On the contrary, the decision to receive 
neuraxial labour analgesia as a last resort was not nega-
tively associated with BIS as compared with women who 
coped with their pain successfully. Therefore, women who 
a priori choose to receive neuraxial labour analgesia and 
express the desire to breast feed the baby are to be consid-
ered at risk of breastfeeding initiation failure. Further 
studies are desirable to fully elucidate if these women 
can benefit from increased breastfeeding support and 
customised strategies implemented by health providers.
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